Key Takeaways Clinical State Best Drug Why Chronic / Stable Labetalol or Amlodipine Safe, non-dialyzable, long duration During Dialysis (High BP) Labetalol Rapid, stable control Emergency (No ischemia) IV Labetalol / Nicardipine Smooth, predictable Emergency (With ischemia / pulmonary edema) IV Nitroglycerin Relieves ischemia & congestion Resistant HTN Hydralazine or Minoxidil + -blocker Adjunctive use only DRYASERALWALI To view or add a comment, sign in BEMPEDOIC ACID GETS CLASS I, LEVEL A RECOMMENDATION: (Focused Update 2025 ESC/EAS Guidelines on Dyslipidaemias) The 2025 Focused Update of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) guidelines marks a major shift: for the first time, a non-statin agent, bempedoic acid, has received the highest-level endorsement (Class I, Level A) for cardiovascular risk reduction in patients unable to take statins
Garvey: Well, I think, you know, its early on
(2001) Isolated rat stomach ECL cells generate prostaglandin E2 in response to interleukin-1, tumor necrosis factor- and bradykinin Eur
For telehealth platforms and compounders, it increases scrutiny over how personalized versions are formulated and mixednot just how they are marketed
